Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model‐Informed Drug Development Perspective

Ähnliche Einträge

• Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future
  von: Rajesh Krishna, et al.
  Veröffentlicht: (2024)
• New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
  von: Amitava Mitra, et al.
  Veröffentlicht: (2024)
• Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
  von: Mariam A. Ahmed, et al.
  Veröffentlicht: (2024)
• Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
  von: Jie Chen, et al.
  Veröffentlicht: (2025)
• Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective
  von: Jie Chen, et al.
  Veröffentlicht: (2025)